(Total Views: 662)
Posted On: 10/05/2020 12:38:37 PM
Post# of 154094
Competition:
Please contact AmSECT Headquarters with any questions or concerns.
Webinar: Rationale and Practical Use of CytoSorb
Register for the Next Joint Perfusion COVID-19 Task Force Webinar This Thursday, October 8
Join the Joint Perfusion COVID-19 Task Force and CytoSorbents Corporation for a webinar on Thursday, October 8 at 2:00 pm ET/1:00 pm CT. Topics to be discussed are the rationale and practical use of CytoSorb, an extracorporeal cytokine adsorber, with ECMO to treat cytokine storm in critically ill COVID-19 patients.
Rationale and Practical use of CytoSorb, an Extracorporeal Cytokine Adsorber, with ECMO to Treat Cytokine Storm in Critically-Ill COVID-19 patients
Thursday, October 8 at 2:00 pm ET/1:00 pm CT/12:00 pm MT/11:00 am PT
Please note: This webinar will last 1 hour and 30 minutes
Moderators:
Linda Mongero, Vice President, ECLS/ECMO, SpecialtyCare
Luc Puis, Tiny Perfusion Letter
Speakers:
Phillip Chan, MD, Ph.D., CEO CytoSorbents Corporation, covering: CytoSorb and ECMO: A Novel "Lung Resting" Strategy in Critically-Ill COVID-19 patients under FDA Emergency Use Authorization
Stefan Sajgo, Ulm University, Ulm Germany, covering: Practical Experience in Treatment of COVID-19 Patients in Combination with ECMO and CytoSorb
https://www.amsect.org/page/covid-19
Yes, they have EUA for COVID
Please contact AmSECT Headquarters with any questions or concerns.
Webinar: Rationale and Practical Use of CytoSorb
Register for the Next Joint Perfusion COVID-19 Task Force Webinar This Thursday, October 8
Join the Joint Perfusion COVID-19 Task Force and CytoSorbents Corporation for a webinar on Thursday, October 8 at 2:00 pm ET/1:00 pm CT. Topics to be discussed are the rationale and practical use of CytoSorb, an extracorporeal cytokine adsorber, with ECMO to treat cytokine storm in critically ill COVID-19 patients.
Rationale and Practical use of CytoSorb, an Extracorporeal Cytokine Adsorber, with ECMO to Treat Cytokine Storm in Critically-Ill COVID-19 patients
Thursday, October 8 at 2:00 pm ET/1:00 pm CT/12:00 pm MT/11:00 am PT
Please note: This webinar will last 1 hour and 30 minutes
Moderators:
Linda Mongero, Vice President, ECLS/ECMO, SpecialtyCare
Luc Puis, Tiny Perfusion Letter
Speakers:
Phillip Chan, MD, Ph.D., CEO CytoSorbents Corporation, covering: CytoSorb and ECMO: A Novel "Lung Resting" Strategy in Critically-Ill COVID-19 patients under FDA Emergency Use Authorization
Stefan Sajgo, Ulm University, Ulm Germany, covering: Practical Experience in Treatment of COVID-19 Patients in Combination with ECMO and CytoSorb
https://www.amsect.org/page/covid-19
Yes, they have EUA for COVID
(0)
(0)
